Company Profile
Updated: 30-OCT-09Lotus Capital Ltd.
International Private company
1b Udi St., Osborne Foreshore Estate, Osborne Rd., Ikoyi, , Nigeria
()234 01 271 3280, 234 01 271 3284 fax, http://www.lotuscapitallimited.com
Primary SIC: Functions Rel to Deposit Banking, Not Elsewhere Classified, Primary NAICS: Financial Transactions Processing, Reserve, and Clearing House Activities
Description: Finance: Full-service, ethical investment management boutique specializing in Shari'ah compliant Asset Management, Private Wealth Management Advisory Services and Financial Advisory Services.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
New Zealand : IBM Beefs Up Cloud Computing Resources.
TendersInfo; 12/11/2009; 828 words; ...computing applications based on IBM's Lotus software. That lab will be an arm of IBM...centers is a growing business because of the capital investments required to upgrade them...month. Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba...
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores.
PR Newswire; 11/30/2009; 965 words; ...the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development pipeline...relationships with customers, access to capital, increased costs, difficulties...
Cambodia: Royal Group completes full buyout of Mobitel.
TendersInfo; 11/28/2009; 811 words; ...investment firm Cambodia Capital. The firm, which is...financial services provider Lotus Capital, acted as financial adviser...founding partner in Cambodia Capital, described the deal as...Euclid Infotech Pvt. Ltd. Provided by Syndigate...
Lotus Pharmaceuticals, Inc. Announces Certain Clarification to its Annual Report on Form 10-K for the year ended December 31, 2008 and Quarterly Report for the Quarter ended June 30, 2009.
PR Newswire; 11/5/2009; 900 words; ...national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus's current drug development pipeline is focused on the treatment of cerebro...
AGY Therapeutics Series C: $31.3M For Three Programs.
BIOWORLD Today; 11/4/2009; 1103 words; ...York, and HBM Bioventures Ltd., of Zurich, Switzerland...Taipei; Cheng Xin Venture Capital, of Taipei; MIC Capital LLC, of Tokyo; Lotus Bioscience Ventures Ltd., of Hong Kong; the...San Diego; Jafco Co. Ltd., of Palo Alto, Calif...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning